Mayon practices corporate and securities law, with a focus on public offerings and other capital markets transactions. She works across a broad range of sectors and industries, including software, internet, life sciences, retail, telecommunications, hardware, and energy and clean technology. Mayon represents both corporations and investment banks in IPOs and complex capital markets transactions. She also advises late-stage private companies on the IPO process and represents public companies in corporate governance matters and reporting obligations.
“As our Northern California platform continues to grow in line with client and market demand, we are seeing more and more of our late-stage, public company and underwriter client base looking to Goodwin for capital markets capabilities and support,” said Co-Chair of Goodwin’s Capital Markets practice and a partner in the firm’s Technology Companies practice. “Heidi’s extensive capital markets experience, especially as it relates to IPOs, corporate governance and reporting obligations, is a perfect fit for the needs of both our company and underwriter clients, across both technology and life sciences industries. We are thrilled to welcome Heidi to Goodwin.”
Mayon is a frequent speaker on topics relating to capital markets transactions. She co-authored several chapters discussing IPO processes in the widely used treatise, Venture Capital and Public Offering Negotiation. She recently co-authored a chapter in the NYSE Entrepreneur’s Roadmap: From Concept to IPO. She is a member of Law360’s Capital Markets Advisory Board.
Mayon received her J.D. from the University of San Francisco and her B.A. from the University of San Diego. She is admitted to practice in California. She can be reached at firstname.lastname@example.org and 650.752.3227.
Mayon’s appointment follows Goodwin’s continued expansion in Northern California, where the firm recently welcomed some of the country’s leading technology, life sciences, and private equity industry practitioners, including Josh Cook and Jon Novotny, Shane Albright, Darryl M. Woo, and Scott Joachim and David Johanson.
Goodwin’s Technology, Life Sciences and Capital Markets practices are among the most active in the market. The Technology practice is consistently rated in the top five most active of all law firms for venture capital, IPOs and M&A. The Capital Markets practice has advised clients in roughly 580 public offerings with an aggregate value approaching $80 billion over the past five years. In 2018 to date, the Life Sciences practice represented twenty five biotechnology companies on their public offerings with a collective value close to $4.4 billion.